Acceleron Pharma Inc (OQ:XLRN)

Business Focus: Bio Therapeutic Drugs

Recent Price for XLRN
USD 35.050 N/A (N/A)
NASDAQ Delayed 15 minutes
Sep 21 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.000 N/A N/A 1,543.67
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.000 0.0% 514,188  

Latest 10 SEC filings (by transaction date) for XLRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 14/17 Sep 13/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -8 $38.12
Sep 14/17 Sep 13/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -8 $38.03
Sep 14/17 Sep 12/17 Rovaldi Christopher Direct Ownership Common Stock S - Open market or private sale -100 $39.96
Sep 14/17 Sep 12/17 Rovaldi Christopher Direct Ownership Common Stock S - Open market or private sale -1,165 $39.30
Sep 14/17 Sep 12/17 Rovaldi Christopher Direct Ownership Common Stock S - Open market or private sale -12,735 $38.32
Sep 14/17 Sep 12/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -500 $39.39
Sep 14/17 Sep 12/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -4,605 $38.31
Sep 14/17 Sep 12/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -600 $39.37
Sep 14/17 Sep 12/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -4,505 $38.29
Sep 14/17 Sep 12/17 Sherman Matthew L Direct Ownership Common Stock S - Open market or private sale -150 $39.91
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for XLRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 14/17 Sep 12/17 Rovaldi Christopher Direct Ownership Common Stock S - Open market or private sale -100 $39.96
Sep 14/17 Sep 12/17 Rovaldi Christopher Direct Ownership Common Stock S - Open market or private sale -1,165 $39.30
Sep 14/17 Sep 12/17 Rovaldi Christopher Direct Ownership Common Stock S - Open market or private sale -12,735 $38.32
Sep 14/17 Sep 13/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -8 $38.12
Sep 14/17 Sep 12/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -500 $39.39
Sep 14/17 Sep 12/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -4,605 $38.31
Sep 14/17 Sep 13/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -8 $38.03
Sep 14/17 Sep 12/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -600 $39.37
Sep 14/17 Sep 12/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -4,505 $38.29
Sep 14/17 Sep 12/17 Sherman Matthew L Direct Ownership Common Stock S - Open market or private sale -150 $39.91
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $XLRN

StockTwits